ABSTRACT: A whole cell Renibacterium salrnoninarum vaccine was developed using 37°C heat treated cells that were subsequently formalin fixed; this treatment reduced bacterial hydrophobicity and cell associated p57. Coho salmon Oncorhynchus kisutch were immunized with the p57-vaccine by either a combination of intraperitoneal (ip) and intramuscular (im) injections or per OS. In the first experiment, ip/im vaccination of coho salmon with p57-cells in Freund's Incomplete Adjuvant (FIA) conferred a statistically significant increase in mean time to death after the salmon were ip challenged with 4.1 X 106 colony forming units (cfu) of R. salmoninarum. There was no significant difference in response between fish immunized with R. salmoninarum cell surface extract in FIA and those immunized with extracellular protein (ECP) concentrated from culture supernatant in FIA. The ip challenge dose resulted in complete mortality of all fish by Day 43. In a second experiment, fish were orally vaccinated with p57-R. salmoninarum cells encased in a pH protected, enteric-coated antigen microsphere (ECAM). Fish were bath challenged with 4.2 x 10' cfu ml-' on Day 0 and sampled at time points of 0 (pre-challenge), 50, 90, or 150 d immersion challenge. Vaccine efficacy was determined by monitoring the elaboration of p57 in the kidneys of vaccinated and control fish. Fish vaccinated orally demonstrated a significantly lower concentration of p57 (p < 0.01) at Day 150 post challenge compared to fish receiving ECAMs alone. Fish receiving p57-cells without ECAM coating also showed a significantly lower p57 level ( p < 0.03) versus control. In contrast, fish injected intraperitoneally with the p57-cells or fish fed p57' R. salmoninarum cells in ECAMs demonstrated no significant difference (p > 0.05) versus controls. In summary, these studies suggest the preliminary efficacy of 37°C treatment of R. salmoninarum cells as an oral bacterial kidney disease vaccine.
INTRODUCTION
The first reports of bacterial kidney disease (BKD) of salmon were made over 60 yr ago (Belding & Merrill 1935) . To date, the disease remains one of the most problematic bacterial diseases of salmonids in the aquaculture industry. The responsible organism, Renibacterium salmoninarum, is a fastidious, slow growing, non-motile, Gram-positive, facultative intracellular parasite (Fryer & Sanders 1981) which causes a chronic and often fatal disease in a wide range of wild and cultured salmonid species (Austin & Austin 1987) . The disease can cause severe losses among intensively cultured salrnonids (Bullock & Herman 1988) and can be transmitted directly by the feeding of raw viscera of infected fish (Wood & Wallis 1955) or horizontally from infected fish sharing the same water supply (Mitchum & Sherman 1981 , Bell et al. 1984 . Reliance on diet modification, chemotherapy, and selective segregation of infected brood stock has been the only effective, albeit limited, means of controlling disease outbreaks ing the mean day to death for evaluation of vaccine (Elliott et al. 1989) .
efficacy.
Prophylactic treatment through vaccination offers an
In this manuscript, we describe the efficacy of the ideal alternative for the control of BKD. However, 37°C treated (p577 cell in affording protection upon ip investigators have had limited success at achieving a as well as in bath challenge. The prototype vaccine protective immune response against Renibacterium was administered intraperitoneally as well as orally salmoninarum using standard methods for vaccine using enteric coated antigen microspheres (ECAMs). preparation (Patterson et al. 1981 , McCarthy et al. 1984 , Bruno 1988 , Sakai et al. 1989 , Evenden et al. 1993 . Reasons for this limited success may be due to MATERIALS AND METHODS our general lack of knowledge of the mechanisms of pathogenesis and salmonid defense (Kaattari et al. Salmon. Coho salmon Oncorhynchus kisutch were 1988a,b). Also, failure to establish a reliable and natobtained from the Oregon Department of Fish and ural challenge procedure has limited the success in Wildlife hatchery at Sandy, Oregon. Fish were kept at this arena (Evenden et al. 1993) .
the Salmon Disease Laboratory, Oregon State UniverElimination of virulence factors from a prototype sity, in 12°C water. Wildlife, Oregon State University, Corvallis, OR) was exotoxin activities have also been described (Bruno & grown in seven 1 1 volumes in 2.5 1 low form, culture Munro 1982, Shieh 1988 , Evenden et al. 1993 ). Bruno flasks (VWR) with continuous shaking at 17°C; KDM-I1 (1988) found that isolates which do not auto-agglutimedium prepared according to Evelyn (1977) except nate have a reduced cell surface hydrophobicity and without serum supplementation was used. Bacteria are less virulent. These isolates also lack a saline were grown for 7 to 8 d until an absorbance between extractable 57 kDa protein (p57) (Bruno 1990 ). Work 0.4 and 0.8 (525 nm) was generated. Cells were pelin our laboratory has identified an endogenous, PMSF leted by 6000 X g centrifugation for 30 min and resussensitive, protease activity that can be enhanced by pended in 100 m1 cold phosphate buffered saline (PBS; heat treating R. salrnoninarum cells at 37°C for > l 0 h 0.85% NaCl, 10 mM NaPO,, pH 7.2). After a second (Rockey et al. 1991 , Wood & Kaattari 1996 . This treatcentrifugation, the cells were placed in microfuge ment results in reduced cell associated p57 and cell tubes and frozen at -70°C for further use. Extracellular surface hydrophobicity (Piganelli et al. 1998, in this protein (ECP) was extracted from culture supernatants issue). We previously hypothesized that removal of as previously described (Wiens & Kaattari 1989) . p57 may allow a protective immune response (KaatPreparation of bacterial cell surface extract (CSE). tari et al. 198813) .
A CSE was prepared according to the method of Daly Until recently, lack of a natural challenge procedure & Stevenson (1990) . Briefly, 2 to 4 g wet weight of bachas also impeded vaccine research (Elliott et al. 1991, terial cells was washed with 100 m1 of sterile PBS and Murray et al. 1992) . Previous challenge procedures pelleted at 6000 x g for 30 min. Cells were resuspended have utilized intraperitoneal (ip) injection of live cells in 100 m1 of double distilled water for 1 h on ice and the (Bell et al. 1984) ; however, this method bypasses the cells were repelleted, the supernatant removed and skin and mucus, the first line of defense of the fish, precipitated with the addition of powdered ammonium and, therefore, is not relevant to natural exposure sulfate to yield a final 50% weight/volume solution. (Murray et al. 1992) .
The CSE was dialyzed 3 x against PBS overnight and Alternatively, new challenge procedures consisting filter sterilized (0.45 pm, Gelman Scientific). Protein of bath challenges and prolonged incubation periods concentration was determined by the method of Lowry may more closely simulate natural exposure (Elliott et et al. (1951 , Murray et al. 1992 . Also, protocols such as Vaccine preparation. Previously harvested cells were the soluble antigen enzyme-linked immunosorbent thawed from -70°C, microfuged for 2 min (750 X g), assays (ELISAS), which monitor the production of exweighed and resuspended to 200 mg ml-' in sterile, pressed antigen, can be used to detect the progression cold PBS. Cells were placed at 37OC for 48 h. Upon of the disease throughout the entire challenge period completion of incubation, cells were microfuged and (Pascho & Mulchay 1987 , Rockey et al. 1991 . This resuspended into 3 % formalin PBS at 17°C for 10 h. latter procedure eliminates the necessity of solely notCells were washed 3x with 1 m1 PBS and re-weighed.
Antigen preparation for the intraperitoneallintramuscular vaccination and challenge experiment. Antigens for the ip/im immunization and challenge experiment were prepared as follows: All antigens tested as well as 1 PBS control were emulsified in Freund's Incomplete Adjuvant (FIA) for 4 min at 100 units on a Virtis '23' mixer (Virtis Co., Gardiner, NY). PBS and PBS/FIA alone served as controls. The emulsified antigens were as follows: 37°C heat treated p57-Renibacterium salmoninarum cells (500 pg), CSE (50 pg) from water washed whole cells, and ECP (50 pg) concentrated from culture supernatants as described previously (Wiens & Kaattari 1989) . Injections were given intraperitoneally and intramuscularly, in a total volume of 0.1 ml, delivering 0.05 m1 in each site using a 23 gauge needle. Boosts were followed 45 d after primary injection and consisted of one half the quantities used in the primary injection contained in the same total volume. A secondary boost was given 10 d after the first boost; the concentrations of the antigens remained the same as in the first boost. Triplicate tanks containing 45 fish tank-' were used to test the 3 vaccine treatments and 2 controls.
Intraperitoneal challenge. Renibacterium salmoninarum used in the challenge was grown for 7 d in KDM-I1 and washed l x in PBS. Cells were resuspended in sterile PBS to a final absorbance of 0.2 (525 nm) and delivered intraperitoneally to the fish. Plate counts confirmed the challenge dose to be 4.1 X 106 colony forming units (cfu) ml-l. Mortalities were recorded daily. Gram staining and indirect immunofluorescent assay (IFA) (Bullock et al. 1980) were used to confirm the presence of Renibacterium salmoninarum in a portion of the mortalities (data not shown).
Oral vaccine preparation. Previously harvested cells were thawed for use in preparing the respective antigens for oral vaccination. The antigens for the oral ECAM experiment were as follows: ECAMs were prepared by spray-coating the antigen, either 37°C treated (oral p57-) or non-heat treated cells (oral p57+), onto 40-50 mesh dextrose beads (Paulaur Corp., Princeton Junction, NJ) at a dose of 100 pg antigen fish-' d-'. The 100 pg of antigen fish-' d-' was calculated as follows: Based upon a food consumption of 7 g d-' for the 25 fish in each tank, 1.5 g of beads (40-50 mesh dextrose beads), containing 2.5 mg of antigen, was incorporated into 7 g of fish diet. Therefore, the 2.5 mg of antigen given to the 25 fish in each tank is equal to 100 pg antigen fish-' d-l. The beads were then spray-coated with Eudragit L-30D, a commercially available aqueous, pH-reactive latex dispersion of methacrylic-acrylic acid CO-polymer. The 37°C treated p57-cells were also coated and administered at a 100 pg fish-' d-' dosage without the pH-reactive polymer to serve as a non-pH protected control (oral NPP p57-). The final control consisted of non-antigen coated, pH protected ECAMs alone (control). The ECAMs were mixed uniformly throughout the mash of Oregon Moist Pellet (BioProducts) and distilled water was added to form a mull. The mixture was then extruded through a defined pore size extruder (Vitano, EastLake, OH) and was cut into pellets. The fish were fed the respective ECAMs incorporated in their diet. The fish received ECAM incorporated feed on an every other day basis for a total of 30 d. An ip injection treatment was incorporated in the oral vaccine study and consisted of 37°C heat treated p57-emulsified in FIA (ip p577 as described, with modifications to injection. Fish received 500 pg injected in a volume of 0.1 m1 anterior to the pelvic fin using a 26 gauge needle. The boost schedule for the ip group followed the same schedule as the previously described ip injection experiment. After ECAM and ip injection schedules were complete the fish were rested 20 d and then challenged.
Triplicate tanks containing 25 fish tank-' were used to test the 4 vaccine treatments and the 1 control. To monitor the humoral responses and pre-challenge soluble antigen titers, 5 fish tank-' were sacrificed. Sera and kidney samples were collected from 5 fish tank-' prior to challenge, in order to monitor prehumoral and soluble antigen titers.
Bath challenge for oral vaccine experiment. Renibacterium salmoninarum (D6 strain) was grown as previously described. The growth from three 1 1 flasks was combined. Fish were exposed to R. salmoninarum by bath challenge as described by Elliot et al. (1991) with modifications. The water level in each tank was first reduced from 125 to 25 1. The flow of water was then stopped, and supplemental aeration initiated. Viable R. salmoninarum was added to the tanks to give a final concentration of 4.2 X 106 cfu ml-' as determined by plate count. The fish were exposed to the bacteria for 22 h in the standing aerated water. Following the 22 h exposure the water flow was resumed and the tanks were allowed to fill at a rate of 2.8 1 min-l, thus removing bacteria through normal effluent flow. One replicate tank of the non-heat treated (oral p57') vaccinated fish was lost due to interruption of air to the tank.
Determination of antibody activity. Antibody activity titers were ascertained by the use of an ELISA as previously described (Piganelli et al. 1994 , Wood & Kaattari 1996 with modifications. Briefly, each antiserum was titrated on a n ELISA plate (Costar E.I.A/ R. I. A. certified surface chemistry, Cambridge, MA) using formalin fixed non-heat treated Renibactenum salmoninarum as the coating antigen (150 pg ml-l). Each plate contained a titration of an anti-R. salmoninarum hyperimmune serum generated in coho salmon. This latter titration permits normalization of the data and a standardized estimation of the units of activity per m1 serum (Arkoosh & Kaattari 1990) .
ELISA-based monitoring of disease progression. Monitoring the progress of infection after challenge was accomplished using the monoclonal antibodybased ELISA protocol described by Rockey et al. (1991) , with modifications. The ELISA quantifies the amount of p57, a major component of the ECPs produced by Renibacterium salmoninarum. Briefly, 5 fish from each triplicate treatment were euthanized in order to monitor levels of soluble antigen. Kidney samples were taken at 0 (pre-challenge), 50, 90 and 150 d post challenge. Samples were collected from fish using fresh collection tools for each individual to minimize cross-contamination. Samples were placed into microfuge tubes held on ice and then mixed 1:l (weight:volume) with cold 1 % bovine serum albumin in Tween 20-Tris buffered saline (BSA/TTBS) (50 mM Tris, 1 mM EDTA, 8.7% NaCl and 0.1 % Tween 20 [pH 8.01). The samples were then homogenized via repeated passage through a 1 m1 syringe. Supernatants were collected as described by Rockey et al. (1991) . ELISAs were performed on all samples according to the protocol of Rockey et al. (1991) , with modifications. Standard concentrations of p57 were run on every plate in order to generate a standard curve. Incubation times were followed as described by Rockey et al. (1991) , and absorbance at 405 nm was measured on a Titertek Multiscan Plus plate reader (Flow Laboratories). Derivation and analysis of the linear equation from the average of triplicate wells for each sample as well as the standard curve were conducted using the Deltasoft ELISA program software package (BioMetallics). The concentration of p57 in each sample was calculated as described by Rockey et al. (1991) , using absorbance values generated from the standard curve. The assay has a baseline detection limit of 3 ng ml-' Polyacrylamide gel electrophoresis and western blotting. Polyacrylamide gel electrophoresis and tvestern blotting were performed as previously described (Wiens & Kaattari 1989 ). Preparat~ons of Renlbactenum salmonlnarum cells used as antigens in the vaccine experiments were electrophoretically analyzed as described in Wiens & Kaattari (1991) .
Statistical analysis. Due to the variance in p57 levels among individual fish, all data were log transformed. Data were analyzed using the l-way analysis of variance (ANOVA) program on the Statgraphics software package. ANOVA generates an F-statistic whlch is subsequently analyzed by the t-test to determine significance using the pooled standard deviation (SP2). The 99 and 95 % confidence limits were derived using standard error of the mean.
RESULTS

Total protein and western blot analysis of whole Renibacterium salmoninarum cell vaccine preparations
The removal of p57 after 48 h incubation at 37°C followed by formalin treatment was assessed by both total protein (Fig. 1A) and western blot (Fig. 1B) . Electrophoresis of equal amounts (50 pg) of 37°C and 4°C treated cells revealed a strong p57 band in the 4°C cell lysates but not in the 37°C samples.
Effect of iplim vaccination and challenge
The first vaccine experiment compared the effect of Renibacterium salmoninarum CSE, ECP and 37°C p57-whole cells. Each fish was challenged ip with 4.1 X 106 cfu of live R. salmonlnarum cells. The challenge dose resulted in complete mortality in all tanks by 43 d . No difference in mortality was observed in mean time to death between CSE and ECP vaccine treatments and the saline or saline/FIA controls, ( Fig. 2A-C) . However a significant extension of the mean time to death was observed (p < 0.05) in the p57-tvhole cell vaccine treatment (Fig. 2D) .
Effect of oral (ECAM) or ip vaccination and bath challenge
Fish which were vaccinated by either ECAM (oral) delivery or ip injection were subsequently bath chal- lenged. Progress of the infection was monitored over time by the determination of p57 production. There were no significant differences between treatments versus non-antigen coated control beads (control) at 0 (prechallenge), 50 and 90 d post challenge (Table 1) ; however, by 150 d, significant differences were observed. Fish fed the oral p 5 7 cell vaccine contained significantly less p57 in kidney tissue compared to the controls (p < 0.01) ( Table 1 ). In addition, the oral NPP p57-vaccinated fish contained significantly less p57 in kidney tissue versus controls (p < 0.03). In contrast, at Day 150, the concentration of p57 in the ip p57-and the oral p57' vaccinated groups was not significantly different from the control, ECAM vaccinated group (p > 0.05). 'Control non-antigen coated beads alone; bECAM delivered p57-whole cells; 'Non-pH protected p 5 7 whole cells; d E~~ delivered p57' whole cells; eIntraperitoneal injected p57-whole cells; 'Detection Limit of assay aControl non-antigen coated beads; b~C~~ delivered p57-whole cells; CNon-pH protected p57-whole cells; dECAM delivered p57* whole cells; elntraperitoneal injected p57-whole cells Serum antibody titers were monitored from each fish and the titers indicate that the ip p57-treatment elicited specific serum antibodies to formalin fixed Renibacterium salmoninarum cells throughout the sample period ( Table 2 ). The antibody titers in the ip p57-group were much greater than found in the ECAM vaccinated groups (Table 2 ) and did not correlate with protection as indicated by the high p57 levels in kidney tissue.
DISCUSSION
We examined the efficacy of a vaccine based on the heat treatment of Renibacterium salmoninarum cells administered intraperitoneally by injection as well as orally using ECAMs. The first experiment employed ip injection with a n ip challenge, and demonstrated that a significant increase in mean day to time to death (p < 0.05) was conferred by p57-in FIA whole cell irnrnunization. There was no significant difference between fish immunized with CSE or ECP in FIA compared to the saline or saline/FIA controls, suggesting that components present in or on R. salmoninarum cells may be necessary to elicit protective immunity. While we observed a significant delay in the mean day to death in the p57-vaccine group, the ip exposure chosen for challenge eventually resulted in complete mortality for all fish. The ip route of challenge is problematic as it bypasses the outer integument of the fish and introduces R. salmoninarum in an unnatural way. In fish, unlike mammals, the entire interface with the environment consists of a mucosal epithelium, therefore it would seem that these mucosal surfaces play a critical role in the fish's first line defense (Davidson et al. 1993) . Therefore, a second experiment was conducted in order to assess vaccine efficacy, utdizing a bath challenge as it is a more natural route of pathogen exposure. Challenge by bath immersion has been established to be an effective model for studying Renibacterium sahoninarum infection in a laboratory setting (Murray et al. 1992) . The disadvantage of the bath challenge method is that considerable time is needed to reach significant mortality. This disadvantage has been circumvented with the advent of diagnostic ELISAs that monitor the production of antigens by R. salmoninarum in situ. ELISA analysis of antigen levels allows a more rapid analysis of the progression of infection and provides a means of quantifying vaccine efficacy (Elliott et al. 1991) .
Fish in the second experiment were vaccinated by ECAM feeding or by conventional ip injection. All fish were then bath challenged. The results of this experiment demonstrated that route of administration was important when natural challenge conditions were employed. Fish fed p57-whole cells in ECAMs (oral. p57-) contained significantly lower amounts of p57 in kidney tissues (p < 0.01) at 150 d post challenge as compared to control fish. The increase in p57 concentrations in the kidney of control fish is indicative of Renibacterium salmoninarum infection. Fish fed unprotected p57-cell coated beads (oral NPP p57; without the pH polymer protection) also showed a significant decrease (p < 0.03) in p57 concentration versus control; however, the significance was not as great as with the pH protected ECAMs. The fish fed ECAMs coated with the non-heat treated cells (oral p57+) showed no statistical difference versus controls with respect to p57 levels throughout the entire expenment. Fish receiving an ip injection of p57-cells (ip p573 demonstrated measurable and, on the average, higher units of anti-R. salmoninarum serum antibody throughout the entire experiment, yet p57 amounts were not different from controls.
When the antibody titers were examined, it became apparent that the fish with the most severe disease or hghest concentration of p57 (ip p57-) also possessed the greatest antibody response. Interestingly, groups exhibiting the lowest level of p57 (oral p 5 7 and NPP p57-) possessed the lowest antibody titers. Thus, the appearance of serum antibody titers in these experiments is contraindicative of protection. These results are consistent with other reports which relate that fish exposed to Renibacterium salmoninarum can mount an immune I-esponse as indicated by antibody titers; however, the presence of this has not correlated with protection against the disease (Evelyn 1971 , Patterson et al. 1981 , Bruno 1987 . Recently it has been reported by Davidson et al. (1993) that route of immunization has an impact on the generation of antibody secreting cells in the gut of rainbow trout Oncorhynchus mykiss. They demonstrated that oral immunization produces a faster peak antibody titer (3 wk) in both the intestinal mucosa and head kidney as compared to ip injection (7 wk). The rapid induction of a peak antibody titer in the intestinal mucosa may explain the efficacy of the oral p57-vaccine. A mucosal response may have allowed for protection at the mucosal epithelium, which is crucial for disease resistance when the route of exposure is through mucosal sites (Finlay & Falkow 1989 , McGhee et al. 1991 . Lobb (1986) demonstrated that bath immunization of channel catfish Ictalurus punctatus produced antibody in cutaneous mucus in 5 of 6 individuals following immersion in dinitrophenylated horse serum albumin (DNP-HSA). However, only 1 out of 5 fish demonstrated a marked increase in serum anti-DNP antibody following the bath immersion. Lobb (1986) also demonstrated that the channel catfish possess numerous lymphocytes associated with the epidermis. This study suggests that the channel catfish immune system can respond differentially depending on the route of exposure. Other reports have demonstrated that serum antibody titers of bath or orally immunized fish do not correlate with protection against certain pathogens. Croy & Amend (1977) observed significant protection with bath immunization against vibriosis in the absence of serum titers. Because R. salmoninarum 1s a facultative intracellular parasite, the role of protection by cellular immunity should not be overlooked. However, more work on and development of cell mediated assays are needed to explore this possibility. Recently, Wood & Kaattari (1996) demonstrated that removal of p57-from the R. salmoninarum cell surface by activation of endogenous serine protease resulted in a 20-fold increase in the detectable antibody titer in chinook salmon Oncorhynchus tshawytscha versus the response to intact p57' R. salmoninarum cells. Further treatment of the p57-cells with periodate revealed that the increased antibody response was almost exclusively to unmasked carbohydrate moieties. Clearly, if oral delivery of the ECAMs coated with p57-cells (oral p577 elicited a mucosal immune response to these unmasked carbohydrate antigens, then protection may have been achieved at the initial site of entry. However, we cannot rule out the possibility that other proteins may have also been removed during the heat treatment of the R. salmoninarum cells, which may have contributed to the protection seen with the oral p57-vaccine. It is tempting to speculate that the protection seen in the oral p57-group was due to the removal of the p57 protein, which may have altered the antigenic characteristics recognized by the salmonid immune system.
In conclusion, the results presented here demonstrate that heat treatment of Renibacterium salrnoninarurn cells and route of delivery are critical factors to consider if protection against R. salrnoninarurn infection is to be achieved. The orally delivered p57-cells (oral p577 afforded significant protection when fish were exposed to viable R. salmoninarum by bath immersion, while the ip p57-and oral p57' cells did not. Although in the first experiment the ip p57-vaccine demonstrated a significant delay in mean time to death after ip challenge, the results of the second experiment proved that when salmon were challenged by a natural route this method of immunization was significantly less effective. These results show promise for elucidating the ideal candidate antigen(s) and developing oral vaccines for the stimulation of a protective immune response in salmonids against BKD.
